Clinical Utilities of Microdissected Samples

  • Issac Yi Kim
  • David K. Ornstein
Part of the Principles and Practice book series (PRINCIPLES)


Laser Capture Microdissection Tissue Microdissection Cell Cycle Parameter Microdissected Sample Immunoglobulin Heavy Chain Gene Rearrangement 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ahram M, Flaig MJ, Gillespie JW, Duray PH, Linehan WM, Ornstein DK, Niu S, Zhao Y (2003) Petricoin EF 3rd, and Emmert-Buck MR. Evaluation of ethanol-fixed, paraffin-embedded tissues for proteomic applications. Proteomics 3:413–421CrossRefPubMedGoogle Scholar
  2. Andrulis IL, Bull SB, Blackstein ME, Sutherland D, Mak C, Sidlofsky S, Pritzker KP, Hartwick RW, Hanna W, Lickley L, Wilkinson R, Qizilbash A, Ambus U, Lipa M, Weizel H, Katz A, Baida M, Mariz S, Stoik G, Dacamara P, Strongitharm D, Geddie W, McCready D (1998) Neu/erb-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. J Clin Oncol 16:1340–1349PubMedGoogle Scholar
  3. Baldetorp B, Stal O, Ahrens O, Cornelisse C, Corver W, Falkmer U, Ferno M (1998) Different calculation methods for flow cytometric S-phase fraction: prognostic implication in breast cancer? The Swedish Society of Cancer Study Group. Cytometry 33:385–393CrossRefPubMedGoogle Scholar
  4. Banks RE, Dunn MJ, Forbes MA, Stanley A, Pappin D, Naven T, Gough M, Harnden P, and Selby PJ (1999) The potential use of laser capture microdissection to selectively obtain distinct population of cells for proteomic analysis-preliminary findings. Electrophoresis 20:689–700CrossRefPubMedGoogle Scholar
  5. Cooperberg MR, Lubeck DP, Penson DF, Mehta SS, Carroll PR, Kane CJ (2003) Sociodemographic and clinical risk characteristics of patients with prostate cancer within the veterans affairs health care system: data from CaPSURE. J Urol 170:905–908CrossRefPubMedGoogle Scholar
  6. Cunningham J, Lust JA, Schaid DJ, Bren GD, Carpenter HA, Rizza E, Kovach JS, Thibodeau SN (1992) Expression of p53 and 17p allelic loss in colorectal carcinoma. Cancer Res 52(7):1974–1980PubMedGoogle Scholar
  7. Curran S, McKay JA, McLeod HL, Murray GI (2000) Laser capture microscopy. Mol Pathol 53:64–68PubMedGoogle Scholar
  8. De Haas RR, Verwoerd NP, van der Corput MP, van Gijlswijk RP, Siitari H, Tanke HJ (1996) The use of peroxide-mediated deposition of biotin-tyramide in combination wit h time-resolved fluorescence imaging of europium chelate label in immunohistochemistry and in situ hybridization. J Histochem Cytochem 44:237–243Google Scholar
  9. De Preter K, Vandesompele J, Heimann P, Kockx MM, Van Gele M, Hoebeeck J, De Smet E, Demarche M, Laureys G, Van Roy N, De Paepe A, Speleman F (2003) Application of laser capture microdissection in genetic analysis of neuroblastoma and neuroblastoma precursor cells. Cancer Lett 197:53–61PubMedGoogle Scholar
  10. DiFrancesco LM, Murthy SK, Luider J, Demetrick DJ (2000) Laser capture microdissection-guided fluorescence in situ hybridization and flow cytometric cell cycle analysis of purified nuclei from paraffin sections. Meth Pathol 13:705–711Google Scholar
  11. Eccles DM, Brett L, Lessells A, Gruber L, Lane D, Steel CM, Leonard RC (1992) Overexpression of the p53 protein and allele loss at 17pl3 in ovarian carcinoma. Br J Cancer 65:40–44PubMedGoogle Scholar
  12. Eissa S, Khalifa A, el-Gharib A, Salah N, Mohamed MK (1997) Multivariate analysis of DNA ploidy, p53, c-erb-2 proteins, EGFR, and steroid hormone receptors for short-term prognosis in breast cancer. Anticancer Res 17:3091–3097PubMedGoogle Scholar
  13. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA, Liotta LA (1996) Laser capture microdissection. Science 274:998–1001CrossRefPubMedGoogle Scholar
  14. Emmert-Buck MR, Gillespie JW, Paweletz CP, Ornstein DK, Basrur V, Appella E, Wang QH, Huang J, Hu N, Taylor P, Petricoin EF 3rd (2000) An approach to proteomic analysis of human tumors. Mol Carcinog 27:158–165CrossRefPubMedGoogle Scholar
  15. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove CA (1983) Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. Cytochemistry 31:1333–1335Google Scholar
  16. Heiden T, Wang N, Bernhard T (1991) An improved Hedley method for preparation of paraffin-embedded tissues for flow-cytometric analysis of ploidy and S phase. Cytometry 12:614–621CrossRefPubMedGoogle Scholar
  17. Hunt JL, Swalsky P, Sasatomi E, Niehouse L, Bakker A, Finkelstein SD (2003) A microdissection and molecular genotyping assay to confirm the identity of tissue floaters in paraffin-embedded tissue blocks. Arch Pathol Lab Med 127:213–217PubMedGoogle Scholar
  18. Hyytinen E, Visakorpi T, Kallioniemi OP, Isola JJ (1994) Improved technique for analysis of formalin-fixed, paraffin embedded tumors by fluorescence in situ hybridization. Cytometry 16:93–99CrossRefPubMedGoogle Scholar
  19. Junying J, Herrmann K, Davies G, Lissauer D, Bell A, Timms J, Reynolds GM, Hubscher SG, Young LS, Niedobitek G, Murray PG (2003) Absence of Epstein-Barr virus DNA in the tumor cells of European hepatocellular carcinoma. Virology 306:236–243CrossRefPubMedGoogle Scholar
  20. Maris JM, Matthay KK (1999) Molecular biology of neuroblastoma. J Clin Oncol 17:2264–2279PubMedGoogle Scholar
  21. McCormick SR, Peters AA, Schrauth JB (1998) Flow cytometric DNA analysis with cytokeratin gating of formalin-fixed deparffinized breast cancer nuclei. Am J Clin Pathol 110:227–237PubMedGoogle Scholar
  22. McKay JA, Murray GI, Keith WN, McLeod HL (1997) Amplification of fluorescent in situ hybridization signals in formalin fixed paraffin wax embedded section of colon tumor using biotinylated tyramide. Mol Pathol 50:322–325PubMedGoogle Scholar
  23. Miura K, Bowman ED, Simon R, Peng AC, Robles AI, Jone RT, Katagiri T, He P, Mizukami H, Charboneau L, Kikuchi T, Liotta LA, Nakamura Y, Harris CC (2002) Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco smoking-and prognosis-related molecular profiles. Cancer Res 62:3244–3250PubMedGoogle Scholar
  24. Orba Y, Tanaka S, Nishihara H, Kawamura N, Itoh T, Shimizu M, Sawa H, and Nagashima K (2003) Application of laser capture microdissection to cytologic specimens for the detection of immunoglobulin heavy chain gene rearrangement in patients with malignant lymphoma. Cancer 99:198–204CrossRefPubMedGoogle Scholar
  25. Ornstein DK, Englert C, Gillespie JW, Paweletz CP, Linehan WM, Emmert-Buck MR, and Petricoin EF 3rd (2000a) Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epithelium. Clin Cancer Res 6:353–356PubMedGoogle Scholar
  26. Ornstein DK, Gillespie JW, Paweletz CP, Duray PH, Herring J, Vocke CD, Topalian SL, Bostwick DG, Linehan WM, Petricoin EF 3rd, Emmert-Buck MR (2000b) Proteomic analysis of laser capture microdissected human prostrate cancer and in vitro prostate cell lines. Electrophoresis 21:2235–2242CrossRefPubMedGoogle Scholar
  27. Paradis V, Dargere D, Bonvoust F, Rubbia-Brandt L, Ba N, Bioulac-Sage P, Bedossa P (2000) Clonal analysis of micronodules in virus C-induced liver cirrhosis using laser capture microdissection (LCM) and HUMARA assay. Lab Invest 80(10):1553–1559PubMedGoogle Scholar
  28. Paweletz CP, Charboneau L, Bichsel VE, Simone NL, Chen T, Gillespie JW, Emmert-Buck MR, Roth MJ, Petricoin III EF, Liotta LA (2001a) Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20:1981–1989CrossRefPubMedGoogle Scholar
  29. Paweletz CP, Liotta LA, Petricoin III EF (2001b) New technologies for biomarker analysis of prostate cancer progression: laser capture microdissection and tissue proteomics. Urology 57:160–163CrossRefPubMedGoogle Scholar
  30. Qian J, Bostwick DG, Takahashi S, Borell TJ, Brown JA, Lieber MM, Jenkins RB (1996) Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens. Am J Pathol 149:1193–1199PubMedGoogle Scholar
  31. Reissmann PT, Koga H, Takahashi R, Figlin RA, Holmes EC, Piantadosi S, Cordon-Cardo C, Slamon DJ (1993) Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group. Oncogene 8:1913–1919PubMedGoogle Scholar
  32. Ross JS, Sheehan C, Hayner-Buchan AM, Ambros RA, Kallakury BV, Kaufman R, Fisher HA, Muraca PJ (1997) HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization. Human Pathol 28:827–833Google Scholar
  33. Sauter G, Carroll P, Moch H, Kallioniemi A, Kerschmann R, Narayan P, Mihatsch MJ, Waldman FM (1995) C-myc copy number gains in bladder detected by fluorescence in situ hybridization. Am J Pathol 146:1131–1139PubMedGoogle Scholar
  34. Schmidt ML, Lukens JN, Seeger RC, Brodeur GM, Shimada H, Gerbing RB, Stram DO, Perez C, Haase GM, Matthay KK (2000) Biologic factors determine prognosis in infants with stage IV neuroblastoma: a prospective children’s cancer group study. J Clin Oncol (18(6):1260–1268PubMedGoogle Scholar
  35. Sugawara Y, Mizugaki Y, Uchida T, Torii T, Imai S, Makuuchi M, Takada K (1999) Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression. Virology 256:196–202CrossRefPubMedGoogle Scholar
  36. Sugawara Y, Makuuchi M, Takada K (2000) Detection of Epstein-Barr virus DNA in hepatocellular carcinoma tisseuse from hepatitis C-positive patients. Scand J Gastroentrerol 35:981–984Google Scholar
  37. Thompson AM, Anderson TJ, Condie A, Prosser J, Chetty U, Carter DC, Evans HJ, Steel CM (1992) p53 allele losses, mutations, and expression in breast cancer and their relationship to clinico-pathological parameters. Int J Cancer 50:528–532PubMedGoogle Scholar
  38. Trillo-Pazos G, Diamanturos A, Rislove L, Menza T, Chao W, Belem P, Sadiq S, Morgello S, Sharer L, Volsky DJ (2003) Detection of HVI-1 DNA in microglia/macrophages, astrocytes, and neurons isolated from brain tissues with HIV-1 encephalitis by laser capture microdissection. Brain Pathol 13:144–154PubMedGoogle Scholar
  39. Tsuda H, Sakamaki C, Tsugane S, Fukutomi T, Hirohashi S (1998) A prospective study of the significance of gene and chromosome alterations as prognostic indicators of breast cancer patients with lymph node metastases. Breast Cancer Res Treat 48:21–32CrossRefPubMedGoogle Scholar
  40. Wong SW, Rangan AM, Bilous AM, Boyages J, Gebski V, Benson EM (1999) The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting. Pathology 31:90–94PubMedGoogle Scholar

Copyright information

© Springer Berlin Heidelberg 2005

Authors and Affiliations

  • Issac Yi Kim
  • David K. Ornstein

There are no affiliations available

Personalised recommendations